Analysts Offer Insights on Healthcare Companies: Scholar Rock Holding (SRRK) and Nuvation Bio (NUVB)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Scholar Rock Holding (SRRK – Research Report) and Nuvation Bio (NUVB – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Scholar Rock Holding (SRRK)
H.C. Wainwright analyst Andres Y. Maldonado maintained a Buy rating on Scholar Rock Holding today and set a price target of $58.00. The company’s shares closed last Tuesday at $46.01, close to its 52-week high of $46.98.
According to TipRanks.com, Maldonado is a 5-star analyst with an average return of
Currently, the analyst consensus on Scholar Rock Holding is a Strong Buy with an average price target of $53.50.
See the top stocks recommended by analysts >>
Nuvation Bio (NUVB)
The company’s shares closed last Tuesday at $4.33.
According to TipRanks.com, Roy is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Currently, the analyst consensus on Nuvation Bio is a Strong Buy with an average price target of $12.00, a 149.5% upside from current levels. In a report released yesterday, RBC Capital also maintained a Buy rating on the stock with a $13.00 price target.
